Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diagnostic tools in looking for a way to improve prevention, understanding, diagnosis, treatment and follow-up of coagulation-related pathologies.
I am pleased to introduce Stago ANZ and the outstanding people who work for this organisation.
After 60 years in the haemostasis field and widely regarded as a leader in the industry, Diagnostica Stago decided to establish a subsidiary in Australia and New Zealand in 2008.
The establishment of the ANZ subsidiary provided an opportunity to expand on this mission and build relationships within a market well advanced in these areas of pathology.
Our formula for success is simple: we strive to attract the most capable people possible, we maintain a work environment that focuses on the needs of our customers, and the company with the strong backing of the parent in France, provides the necessary financial and technical resources to maximise results.
Our guiding principle with our clients is that the relationship is not just for one transaction but for the long term. This view encourages closer partnerships, better understanding of our client’s issues and a greater commitment to servicing their needs at all times.
We believe that for a company to succeed it must differentiate itself from its competition, and in many respects our company is unique within our industry.
Some of the characteristics which assist us in this are:
I think you will find a relationship with Stago ANZ to be extremely rewarding. We welcome the opportunity to assist you with your haemostasis requirements.
Chief Executive Officer